Accessibility Menu
 
Avivagen logo

Avivagen

(OTC) VIVXF

Current Price$0.00
Market CapN/A
Since IPO (2012)-100%
5 Year-100%
1 Year-99%
1 Month-99%

Avivagen Financials at a Glance

Market Cap

N/A

Revenue (TTM)

$715.22K

Net Income (TTM)

$4.64M

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

10.13 (High)

Price

$0.00

Volume

100

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.00

VIVXF News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Avivagen

Industry

Pharmaceuticals

Employees

13

CEO

G. F. Kym Anthony, MBA

Headquarters

Ottawa, ON K1A 0R6, CA

VIVXF Financials

Key Financial Metrics (TTM)

Gross Margin

43%

Operating Margin

-99%

Net Income Margin

-6%

Return on Equity

0%

Return on Capital

1%

Return on Assets

-4%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$0.00

Shares Outstanding

0

Volume

100

Avg. Volume

0

Financials (TTM)

Gross Profit

$400.30K

Operating Income

$4.90M

EBITDA

$4.21M

Operating Cash Flow

$3.12M

Capital Expenditure

$0.00

Free Cash Flow

$3.12M

Cash & ST Invst.

$290.46K

Total Debt

$6.09M

Avivagen Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q3 2023YOY CHG

Revenue

$40.52K

-16.6%

Gross Profit

$23.79K

+8.5%

Gross Margin

58.71%

N/A

Market Cap

$0.00

N/A

Market Cap/Employee

N/A

N/A

Employees

13

N/A

Net Income

$932.92K

+50.9%

EBITDA

$421.33K

+71.0%

Quarterly Fundamentals

Name
Q3 2023YOY CHG

Net Cash

$7.22M

-36.2%

Accounts Receivable

$47.65K

+70.8%

Inventory

$73.71K

-92.2%

Long Term Debt

$1.10M

-78.0%

Short Term Debt

$6.14M

+683.6%

Return on Assets

-4.44%

N/A

Return on Invested Capital

1.27%

N/A

Free Cash Flow

$71.51K

+106.3%

Operating Cash Flow

$71.51K

+106.3%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
CWWBFPlant-Based Investment Corp.
$0.00+0.00%
RLBDReal Brands, Inc.
$0.00+0.00%
PZOOPazoo, Inc.
$0.00+0.00%
AOXGAoxing Pharmaceutical Company, Inc.
$0.01+23.81%

Trending Stocks

Symbol / CompanyPricePrice Chg
NOKNokia
$13.30+0.03%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$13.07+0.05%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$5.70+0.01%
TQQQProShares Trust - ProShares UltraPro Qqq
$65.30+0.03%

Questions About VIVXF

What is the current price of Avivagen?

Avivagen is trading at N/A per share.

What is the 52-week range for Avivagen?

Over the past 52 weeks, Avivagen has traded between N/A and $0.00.

How much debt does Avivagen have?

As of the most recent reporting period, Avivagen reported total debt of $4.44M.

How much cash does Avivagen have on hand?

Avivagen reported $212,937.942 in cash and cash equivalents in its most recent financial results.

What is Avivagen’s dividend yield?

Avivagen does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.